BMN-673 (Talazoparib) Mechanism of Action: PARP Inhibition in Prostate Cancer Cell Research

BMN-673 (Talazoparib) MOA:Targeting PARP/DNA Damage Response Pathway for Metastatic Castration-Resistant Prostate Cancer

🎯 check BMN-673 (Talazoparib) product page

BMN-673 (Talazoparib) is a highly potent PARP1/2 inhibitor. It affects DNA damage response and cGAS-STING signaling pathways by inhibiting PARP catalytic activity and strongly trapping PARP on DNA, thereby inhibiting tumor cell proliferation and promoting apoptosis.

Primary Applications and Mechanism of Action